P
Paul Angulo
Researcher at University of Kentucky
Publications - 193
Citations - 35512
Paul Angulo is an academic researcher from University of Kentucky. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Primary sclerosing cholangitis. The author has an hindex of 77, co-authored 191 publications receiving 32339 citations. Previous affiliations of Paul Angulo include Mayo Clinic & Durham University.
Papers
More filters
Journal ArticleDOI
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
Thomas D. Boyer,Arun J. Sanyal,Florence Wong,R. Todd Frederick,John R. Lake,Jacqueline G. O'Leary,Daniel Ganger,Khurram Jamil,Stephen Chris Pappas,Samuel H. Sigal,Santiago J. Munoz,Vishal C. Patel,Paul Y. Kwo,Jasmohan S. Bajaj,Tarek Hassanein,Kirti Shetty,Rohit Satoskar,K. Rajender Reddy,Marlyn J. Mayo,Victor Araya,Nikroo Hashemi,Eyob Feyssa,Lorenzo Rossaro,David Kravetz,Priya Grewal,Ram Subramanian,Kevin M. Korenblat,Yuri Genyk,Fredric Regenstein,Joseph F. Buell,Nathan J. Shores,Sukru Emre,Andrea Duchini,Atif Zaman,Marco Olivera-Martinez,Michael K. Porayko,Alex S. Befeler,K. Gautham Reddy,Maria Del Pilar Hernandez,Stephen D. Zucker,Hugo E. Vargas,Michael P. Curry,Adnan Said,Kris V. Kowdley,Terry Box,David S. Barnes,Marie Noëlle Pépin,Madhavi Rudraraju,Paul Angulo,Howard Paul Monsour,David S. Wolf,Charles D. Howell,Fredric G. Regenstein,Antonio Sanchez,Hany Elbeshbeshy,Michael B. Fallon,Colin Swales,David A. Sass,Eva Urtasun Sotil,Brendan M. McGuire,Richard Gilroy,Juan A. Guerrero,Mark N. Wong,Obaid S. Shaikh,Stevan A. Gonzalez,Zeid Kayali +65 more
TL;DR: Terlipressin plus albumin was associated with greater improvement in renal function vs albumin alone in patients with cirrhosis and HRS-1, and overall survival was similar between groups.
Journal ArticleDOI
Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.
Muhsin Kaya,Bret T. Petersen,Paul Angulo,Todd H. Baron,James C. Andrews,Christopher J. Gostout,Keith D. Lindor +6 more
TL;DR: Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis and results show clear differences in the properties of balloon dilation and that of stenting.
Journal ArticleDOI
Small-duct primary sclerosing cholangitis: A long-term follow-up study
TL;DR: It is suggested that small‐duct PSC may represent an earlier stage of PSC associated with a significantly better long‐term prognosis than classic PSC, which is associated with end‐stage liver disease with the consequent necessity of liver transplantation.
Journal ArticleDOI
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid
Paul Angulo,Keith D. Lindor,Terry M. Therneau,Roberta A. Jorgensen,Michael Malinchoc,Patrick S. Kamath,E. Rolland Dickson +6 more
TL;DR: Suboptimal responders to UDCA can be identified by assessment of serum alkaline phosphatase levels, and/or Mayo risk score, and the Mayo survival model accurately predicts the clinical course in patients with PBC receiving UDCA.
Journal ArticleDOI
Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system
TL;DR: The new scoring system seems to more precisely define the potential overlap syndrome between PSC and AIH, although further modification of the newscoring system may provide even better discrimination among these conditions.